Intellicell Biosciences, Inc.
Biotechnology company · New York, United States
Intellicell Biosciences, Inc. is a biotechnology company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $375,000 sold in a notice filed in 2012.
Profile compiled from public records. Is this your company? Request a correction or update
Intellicell Biosciences at a glance
Typebiotechnology company
HeadquartersNew York, United States
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1125280
What does Intellicell Biosciences do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $375,000 sold (2012).
Frequently asked questions about Intellicell Biosciences
Where is Intellicell Biosciences headquartered?
Intellicell Biosciences, Inc. is headquartered in New York, United States.
What does Intellicell Biosciences do?
Intellicell Biosciences, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences